Olive Capital is a private investment syndicate focusing on early-stage opportunities in innovative companies across Europe and the US. The firm provides its members access to investment opportunities in private companies at very early stages, typically participating in seed rounds.
Notable portfolio companies include Akasa, Creatordao, and Meliora Therapeutics. Olive Capital leverages its deep network of entrepreneurs to source promising investment opportunities. The syndicate has invested in various sectors, including health tech, biotech, and software, with portfolio companies raising between $2.5 million to $20 million in total funding.
Olive Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies13
Current Portfolio Count13
Top Investment Stages
Seed12 (92.3%)
Series A1 (7.7%)
Stage Mix
Seed 92%Series A 8%
Concentration shown as share of disclosed investments by stage.
